Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge.

apheresis bone marrow transplant gulf middle east stem cells

Journal

Clinics and practice
ISSN: 2039-7275
Titre abrégé: Clin Pract
Pays: Switzerland
ID NLM: 101563282

Informations de publication

Date de publication:
28 Jan 2022
Historique:
received: 22 10 2021
revised: 25 12 2021
accepted: 20 01 2022
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in view of the lack of a comprehensive HSCT facility that could offer the full spectrum of interventions and monitoring protocols. This comes with considerable challenges related to coverage and logistics of travel. It also limits the continuity of clinical care, and presents inconvenience to patients who come from a different cultural background. In this article, we share our experiences and lessons learned during the establishment of the first comprehensive adult and pediatric HSCT unit in the UAE that is designed to cater for local citizens and residents, as well as neighboring countries facing similar availability challenges.

Identifiants

pubmed: 35200262
pii: clinpract12010010
doi: 10.3390/clinpract12010010
pmc: PMC8870922
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

84-90

Références

Bone Marrow Transplant. 2019 Oct;54(10):1525-1552
pubmed: 30953028
J Glob Health. 2021 Mar 27;11:03052
pubmed: 33828836
Gene Ther. 2021 May 26;:
pubmed: 34040164
Bone Marrow Transplant. 2020 Apr;55(4):695-697
pubmed: 31965055
J Glob Oncol. 2018 Sep;4:1-3
pubmed: 30241209
Biol Blood Marrow Transplant. 2019 Dec;25(12):2322-2329
pubmed: 31071457
BMC Cancer. 2020 Jul 10;20(1):641
pubmed: 32650756
Lancet. 2020 Feb 22;395(10224):548
pubmed: 32087781
Gene Ther. 2020 Dec;27(12):537-544
pubmed: 31024072
Br J Haematol. 2016 Dec;175(5):771-783
pubmed: 27748518
Biomed Res Int. 2020 Oct 28;2020:1509501
pubmed: 33178817
J Hematol Oncol. 2020 Jul 2;13(1):86
pubmed: 32616000

Auteurs

Humaid O Al-Shamsi (HO)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.
College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Amin Abyad (A)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Panayotis Kaloyannidis (P)

Adult Hematology and SCT Department, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia.

Amro El-Saddik (A)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Ahmad Alrustamani (A)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Ibrahim Abu Gheida (I)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.

Azzam Ziade (A)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.

Norbert W Dreier (NW)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.

Urfan Ul-Haq (U)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.

Thanda Lucy Ann Joshua (TLA)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
Emirates Oncology Society, Dubai, United Arab Emirates.

Abdul Rahman El Kinge (AR)

NMC Royal Hospital, Sharjah, United Arab Emirates.

Ritika Coelho (R)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Dima Ibrahim (D)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Mehdi Afrit (M)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Bilal Al-Lababidi (B)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Zainul Aabideen (Z)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Mayur Sabhani (M)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Rakeshkumar Shah (R)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Ghaith Makhlouf (G)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Lana Iskandaerani (L)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Faryal Iqbal (F)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Shiny Narayanan (S)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Mohammed Ameen (M)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Theresa Morrison (T)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Charbel Khalil (C)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Kayane Mheidly (K)

Department of Oncology and Innovation and Research Center, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.

Classifications MeSH